Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,705.00
-25.00 (-1.45%)
Sep 4, 2026, 4:36 PM GMT
Bioventix Ratios and Metrics
Market cap in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 90 | 144 | 230 | 201 | 180 | 207 | |
Market Cap Growth | -30.24% | -37.44% | 14.29% | 11.82% | -13.10% | -4.31% |
Enterprise Value | 85 | 139 | 224 | 196 | 175 | 201 |
Last Close Price | 17.30 | 25.51 | 38.74 | 32.58 | 27.88 | 30.69 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 12.31 | 18.95 | 28.37 | 24.00 | 23.42 | 30.72 |
Forward PE | - | 18.42 | 25.47 | 24.22 | 26.92 | 31.02 |
PS Ratio | 7.21 | 10.96 | 16.88 | 15.68 | 15.34 | 18.92 |
PB Ratio | 8.19 | 12.44 | 19.14 | 16.66 | 15.20 | 17.50 |
P/TBV Ratio | 8.19 | 12.44 | 19.14 | 16.66 | 15.20 | 17.50 |
P/FCF Ratio | 11.63 | 20.49 | 27.58 | 25.79 | 23.82 | 34.03 |
P/OCF Ratio | 11.58 | 20.43 | 27.52 | 25.76 | 23.78 | 32.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 6.78 | 10.56 | 16.47 | 15.28 | 14.91 | 18.39 |
EV/EBITDA Ratio | 8.65 | 13.63 | 20.87 | 19.20 | 18.73 | 23.60 |
EV/EBIT Ratio | 8.71 | 13.75 | 21.10 | 19.45 | 19.03 | 23.98 |
EV/FCF Ratio | 10.95 | 19.76 | 26.92 | 25.13 | 23.15 | 33.07 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Debt / Equity Ratio | -0.48 | -0.44 | -0.50 | -0.47 | -0.52 | -0.55 |
Net Debt / EBITDA Ratio | -0.54 | -0.50 | -0.56 | -0.56 | -0.66 | -0.76 |
Net Debt / FCF Ratio | -0.68 | -0.72 | -0.72 | -0.73 | -0.81 | -1.07 |
Asset Turnover | 0.96 | 0.99 | 1.01 | 0.97 | 0.90 | 0.83 |
Inventory Turnover | 1.48 | 1.84 | 1.57 | 1.61 | 1.79 | 2.83 |
Quick Ratio | 5.76 | 4.68 | 4.37 | 5.74 | 5.50 | 7.08 |
Current Ratio | 6.12 | 9.17 | 7.42 | 10.08 | 9.43 | 11.35 |
Return on Equity (ROE) | 66.64% | 64.40% | 67.29% | 70.10% | 64.92% | 55.31% |
Return on Assets (ROA) | 46.91% | 47.35% | 49.17% | 47.68% | 44.10% | 39.98% |
Return on Invested Capital (ROIC) | 127.96% | 121.31% | 131.39% | 138.16% | 137.82% | 142.27% |
Return on Capital Employed (ROCE) | 88.50% | 87.20% | 88.50% | 83.30% | 77.40% | 70.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 8.23% | 5.28% | 3.52% | 4.17% | 4.27% | 3.26% |
FCF Yield | 8.60% | 4.88% | 3.63% | 3.88% | 4.20% | 2.94% |
Dividend Yield | 8.78% | 5.88% | 4.00% | 4.67% | 4.52% | 3.42% |
Payout Ratio | 105.33% | 108.05% | 101.86% | 100.85% | 103.18% | 114.54% |
Buyback Yield / Dilution | 0.08% | 0.08% | -0.14% | -0.56% | 0.03% | -0.76% |
Total Shareholder Return | 8.87% | 5.96% | 3.86% | 4.10% | 4.55% | 2.67% |